BRIAN C BROST, M.D.
Medical Practice at 1 St, Rochester, MN

License number

Minnesota 46175

Organization information

See more information about BRIAN C BROST at bizstanding.com

Mayo Clinic - Brian C Brost MD

200 1 St SW #W4, Rochester, MN 55905

Categories:

Gynecology & Obstetrics Physicians & Surgeons

Phone:

(507) 284-2511 (Phone)

Professional information

Product Manager At Mayo Clinic

Position:

Product Manager at Mayo Clinic

Location:

Rochester, Minnesota

Industry:

Hospital & Health Care

Work:

Mayo Clinic since Jan 2011 - Product Manager Mayo Clinic May 2007 - Feb 2011 - Business Analyst Skyline Exhibits Sep 2002 - May 2007 - Business Analyst

Education:

University of Saint Thomas 1998 - 2002

Skills:

Cross-functional Team Leadership, Data Analysis, Process Improvement

Brian Charles Brost, Faribault MN

Specialties:

Obstetrics & Gynecology, Maternal & Fetal Medicine, Neonatal-Perinatal Medicine

Work:

Cannon Valley Clinic
300 State Ave, Faribault, MN 55021 Mayo Medical School
200 1St St Sw, Rochester, MN 55905

Education:

University of North Carolina (1990)

Brian C Brost, Rochester MN

Specialties:

OB-GYN

Address:

200 1St St Sw, Rochester, MN 55905

Education:

University of North Carolina, School of Medicine - Doctor of Medicine*

Board certifications:

American Board of Obstetrics and Gynecology Certification in Obstetrics & Gynecology*, American Board of Obstetrics and Gynecology Sub-certificate in Maternal and Fetal Medicine (Obstetrics & Gynecology)*

Treating Pre-Eclempsia And Cardiovascular Diseases

US Patent:

2010019, Aug 5, 2010

Filed:

Mar 12, 2008

Appl. No.:

12/530917

Inventors:

Vijayalakshmi Shridhar - Rochester MN, US
Jeremy R. Chien - Rochester MN, US
Brian C. Brost - Rochester MN, US
Funminiyi A. Ajayi - Rochester MN, US

Assignee:

MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH - Rochester MN

International Classification:

G01N 33/53, G01N 33/00

US Classification:

435 792, 436 86

Abstract:

This document relates to methods and materials involved in identifying, predicting, and treating pre-eclampsia or a cardiovascular disease (e.g., atherosclerosis) in mammals. For example, methods and materials involved in using serum levels of HtrA polypeptides to identify pre-eclampsia or a cardiovascular disease, using HTRA polymorphisms to predict pre-eclampsia or a cardiovascular disease, and using HtrA antibodies to treat pre-eclampsia or a cardiovascular disease in mammals (e.g., humans) are provided.

Fetal Heart Rate Monitoring System

US Patent:

2010001, Jan 21, 2010

Filed:

Apr 13, 2007

Appl. No.:

12/297016

Inventors:

Brian C. Brost - Rochester MN, US
Russell E. Bruhnke - Rochester MN, US
Patrick E. Caskey - Rochester MN, US
Stephen A. Contag - Rochester MN, US
Dan Dragomir Daescu - Rochester MN, US
Bruce A. Winter - Rochester MN, US
Jonathon W. Lange - Plainview MN, US

Assignee:

Mayo Foundation for Medical Education and Research - Rochester MN

International Classification:

A61B 5/0444

US Classification:

600511

Abstract:

A fetal heart rate monitoring system includes an ultrasonic transducer for transmitting a signal to a patient and for receiving a reflected heart beat monitoring signal. A monitoring system coupled to the ultrasonic transducer processes the heart beat monitoring signal and produces heart beat information representative of the monitored heart rate. A mechanical or electronic steering system coupled to the ultrasonic transducer controls the location of the signal transmitted to the patent and/or the location of the received heart beat monitoring signal. A control system coupled to the monitor and steering system controls the steering system as a function of the heart beat monitoring signal to optimize the quality of the heart beat information in the received heart beat monitoring signals.